Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...

Micron Technology, Inc. (NASDAQ:MU) is one of the best large-cap stocks to buy right now. On June 26, Baird increased its ...